Scott Robertson
Independent DirectorMr. Scott M. Robertson, BSBS, MBA, serves as Director at Ambros Therapeutics, Inc. since August 2026. He is Independent Director of Bicara Therapeutics Inc. from September 2023. He is Chief Business Officer & CFO of Star Therapeutics, Inc. He was Chief Business Officer of Star Therapeutics, Inc. from January 2024. He was Venture Partner of Finistere Ventures, LLC. He was Associate of MPM BioImpact LLC. He was Non Executive Director of Hexima Limited until September 2023. He was employed at Hexima Limited until September 2023. He was Chief Business & Financial Officer of DiCE Molecules SV, Inc. from August 2021. He was Chief Financial Officer of DiCE Molecules SV, Inc. until August 2021. He was Investment Portfolio Manager of DuPont Ventures. He focused on Production Agriculture, Crop Genetics, Enabling Technologies and Precision Agriculture. He was Chief Business & Financial Officer of DICE Therapeutics, Inc. from July 2021. He has B.S.B.A. from University of Southern California, M.B.A. from Haas School of Business.
Positions
- Company NameBicara Therapeutics Inc.Stock CodeBCAXPositionIndependent DirectorColleagues
- CMClaire Mazumdar ClemonCEO & Director
- MFMichael F. PowellIndependent Chairman of the Board
- RCRyan CohlheppPresident, COO & Director
- JLJennifer LarsonCFO, Treasurer & Principal Accounting Officer
- RFRachel FrankVice President of Investor Relations and Corporate Communications
- LSLara S. MeisnerChief Legal Officer, Compliance Officer & Corporate Secretary
- JSJake SimsonNon Executive Independent Director
